| Segment Reporting, Reconciliation of Revenue by Segment to Consolidated |
Information regarding operations by reportable segment and Corporate and other is presented in the following tables. | | | | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended September 30, | | Nine Months Ended September 30, | | | (In millions) | 2026 | | 2025 | | 2026 | | 2025 | | | Revenues: | | | | | | | | | | Aflac Japan: | | | | | | | | | Net earned premiums (1) | $ | 1,508 | | | $ | 1,663 | | | $ | 4,618 | | | $ | 5,105 | | | | Adjusted net investment income | 639 | | | 665 | | | 1,846 | | | 1,950 | | | | Other income | 9 | | | 7 | | | 25 | | | 24 | | | | Total adjusted revenue Aflac Japan | 2,156 | | | 2,335 | | | 6,489 | | | 7,079 | | | | Aflac U.S.: | | | | | | | | | | Net earned premiums | 1,544 | | | 1,495 | | | 4,638 | | | 4,501 | | | | Adjusted net investment income | 212 | | | 214 | | | 621 | | | 623 | | | | Other income | 25 | | | 19 | | | 72 | | | 53 | | | | Total adjusted revenue Aflac U.S. | 1,781 | | | 1,728 | | | 5,331 | | | 5,177 | | | Corporate and other (2) | 360 | | | 343 | | | 943 | | | 1,005 | | | | Total adjusted revenues | 4,297 | | | 4,406 | | | 12,763 | | | 13,261 | | | | Net investment gains (losses) | (1,072) | | | 275 | | | (1,176) | | | (1,109) | | | | Reconciling items: | | | | | | | | | | Amortized hedge costs | 11 | | | 13 | | | 38 | | | 31 | | | | Amortized hedge income | (14) | | | (20) | | | (51) | | | (80) | | | Net interest (income) expense from derivatives associated with certain investment strategies | 49 | | | 66 | | | 160 | | | 195 | | | | Total revenues | $ | 3,271 | | | $ | 4,740 | | | $ | 11,734 | | | $ | 12,298 | | |
(1) Includes a gain (loss) of $52 and $(55) for the three-month periods and $52 and $(55) for the nine-month periods ended September 30, 2026 and 2025, respectively, related to remeasurement of the deferred profit liability for limited-payment contracts. (2) The change in value of federal historic rehabilitation and solar investments in partnerships of $4 and $6 for the three-month periods and $15 and $22 for the nine-month periods ended September 30, 2026 and 2025, respectively, is included as a reduction to net investment income. Tax credits on these investments of $5 and $7 for the three-month periods and $16 and $24 for the nine-month periods ended September 30, 2026 and 2025, respectively, have been reported as an income tax benefit in the consolidated statements of earnings. See Note 1 of the Notes to the Consolidated Financial Statements in the 2025 Annual Report for additional information on these investments.
|
| Reconciliation of Adjusted Profit (Loss) from Segments to Consolidated |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended September 30, | | Nine Months Ended September 30, | | | (In millions) | 2026 | | 2025 | | 2026 | | 2025 | | | Adjusted revenues: | | | | | | | | | Aflac Japan (1) | $ | 2,156 | | | $ | 2,335 | | | $ | 6,489 | | | $ | 7,079 | | | | Aflac U.S. | 1,781 | | | 1,728 | | | 5,331 | | | 5,177 | | | Corporate and other (2) | 360 | | | 343 | | | 943 | | | 1,005 | | | | Total adjusted revenues | 4,297 | | | 4,406 | | | 12,763 | | | 13,261 | | | | Benefits and adjusted expenses: | | | | | | | | | | Aflac Japan: | | | | | | | | | | Benefits and claims, excluding reserve remeasurement | 938 | | | 1,130 | | | 2,979 | | | 3,446 | | | | Reserve remeasurement (gains) losses | (201) | | | (474) | | | (269) | | | (513) | | | | Total benefits and claims, net | 737 | | | 656 | | | 2,710 | | | 2,933 | | | | Adjusted expenses: | | | | | | | | | | Amortization of deferred policy acquisition costs | 79 | | | 81 | | | 233 | | | 245 | | | | Insurance commissions | 93 | | | 111 | | | 282 | | | 328 | | | | Insurance and other expenses | 286 | | | 271 | | | 803 | | | 845 | | | | Total benefits and adjusted expenses Aflac Japan | 1,195 | | | 1,119 | | | 4,028 | | | 4,351 | | | | Aflac U.S.: | | | | | | | | | | Benefits and claims, excluding reserve remeasurement | 790 | | | 752 | | | 2,342 | | | 2,219 | | | | Reserve remeasurement (gains) losses | (161) | | | (71) | | | (217) | | | (110) | | | | Total benefits and claims, net | 629 | | | 681 | | | 2,125 | | | 2,109 | | | | Adjusted expenses: | | | | | | | | | | Amortization of deferred policy acquisition costs | 141 | | | 137 | | | 426 | | | 410 | | | | Insurance commissions | 144 | | | 143 | | | 431 | | | 417 | | | | Insurance and other expenses | 374 | | | 392 | | | 1,123 | | | 1,120 | | | | Total benefits and adjusted expenses Aflac U.S. | 1,288 | | | 1,353 | | | 4,105 | | | 4,056 | | | | Corporate and other | 288 | | | 274 | | | 881 | | | 873 | | | | Total adjusted expenses | $ | 2,771 | | | $ | 2,746 | | | $ | 9,014 | | | $ | 9,280 | | | | Pretax earnings: | | | | | | | | | Aflac Japan (1) | $ | 961 | | | $ | 1,216 | | | $ | 2,461 | | | $ | 2,728 | | | | Aflac U.S. | 493 | | | 375 | | | 1,226 | | | 1,121 | | | Corporate and other (2) | 72 | | | 69 | | | 62 | | | 132 | | | | Pretax adjusted earnings | 1,526 | | | 1,660 | | | 3,749 | | | 3,981 | | | | Other income (loss) | 0 | | | (1) | | | 0 | | | (54) | | | | Net investment gains (losses) | (1,072) | | | 275 | | | (1,176) | | | (1,109) | | | | Reconciling items: | | | | | | | | | | Amortized hedge costs | 11 | | | 13 | | | 38 | | | 31 | | | | Amortized hedge income | (14) | | | (20) | | | (51) | | | (80) | | | Net interest (income) expense from derivatives associated with certain investment strategies | 49 | | | 66 | | | 160 | | | 195 | | | | Impact of interest from derivatives associated with notes payable | 0 | | | 1 | | | 0 | | | (3) | | | | Total earnings before income taxes | $ | 500 | | | $ | 1,994 | | | $ | 2,720 | | | $ | 2,961 | | | | Income taxes applicable to pretax adjusted earnings | $ | 312 | | | $ | 333 | | | $ | 751 | | | $ | 791 | | | | Effect of foreign currency translation on after-tax adjusted earnings | (14) | | | 1 | | | (49) | | | 16 | | |
(1) Includes a gain (loss) of $52 and $(55) for the three-month periods and $52 and $(55) nine-month periods ended September 30, 2026 and 2025, respectively, related to remeasurement of the deferred profit liability for limited-payment contracts. (2) The change in value of federal historic rehabilitation and solar investments in partnerships of $4 and $6 for the three-month periods and $15 and $22 for the nine-month periods ended September 30, 2026 and 2025, respectively, is included as a reduction to net investment income. Tax credits on these investments of $5 and $7 for the three-month periods and $16 and $24 for the nine-month periods ended September 30, 2026 and 2025, respectively, have been reported as an income tax benefit in the consolidated statements of earnings. See Note 1 of the Notes to the Consolidated Financial Statements in the 2025 Annual Report for additional information on these investments.
|